uridine triphosphate has been researched along with 4-aminopyridine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katusic, ZS; Kinoshita, H | 1 |
| Katusic, ZS; Onoue, H | 1 |
| Bryan, RM; Johnson, TD; Marrelli, SP; Mombouli, JV; You, J | 1 |
| El-Mahmoudy, A; Matsuyama, H; Shimizu, Y; Takewaki, T; Thapaliya, S | 1 |
| Luykenaar, KD; Welsh, DG | 1 |
5 other study(ies) available for uridine triphosphate and 4-aminopyridine
| Article | Year |
|---|---|
Role of potassium channels in relaxations of isolated canine basilar arteries to acidosis.
Topics: 4-Aminopyridine; Acidosis; Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Barium Compounds; Basilar Artery; Calcium Channel Blockers; Charybdotoxin; Chlorides; Dogs; Endothelium, Vascular; Female; Glyburide; Hydrogen-Ion Concentration; Ion Channel Gating; KATP Channels; Male; Molsidomine; Muscle, Smooth, Vascular; Potassium Channels; Potassium Channels, Inwardly Rectifying; Uridine Triphosphate; Vasodilation | 1997 |
Subarachnoid hemorrhage and the role of potassium channels in relaxations of canine basilar artery to nitrovasodilators.
Topics: 4-Aminopyridine; Animals; Basilar Artery; Charybdotoxin; Cyclic GMP; Dogs; Female; Humans; Male; Molsidomine; Nitroprusside; Potassium Channels; Subarachnoid Hemorrhage; Uridine Triphosphate; Vasodilation; Vasodilator Agents | 1998 |
P2u receptor-mediated release of endothelium-derived relaxing factor/nitric oxide and endothelium-derived hyperpolarizing factor from cerebrovascular endothelium in rats.
Topics: 4-Aminopyridine; Animals; Apamin; Barium Compounds; Cerebral Arteries; Cerebrovascular Circulation; Charybdotoxin; Chlorides; Endothelium, Vascular; Enzyme Inhibitors; Glyburide; Hypoglycemic Agents; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxadiazoles; Peptides; Potassium Channels; Potassium Chloride; Quinoxalines; Rats; Rats, Long-Evans; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Tetraethylammonium; Uridine Triphosphate; Vasodilation | 1999 |
An endothelium-derived factor modulates purinergic neurotransmission to mesenteric arterial smooth muscle of hamster.
Topics: 4-Aminopyridine; Adenosine Triphosphate; Animals; Apamin; Biological Factors; Charybdotoxin; Cricetinae; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Fatty Acids, Unsaturated; Glyburide; In Vitro Techniques; Indomethacin; Male; Membrane Potentials; Mesenteric Arteries; Mesocricetus; Muscle, Smooth, Vascular; Neuromuscular Junction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ouabain; Pinacidil; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Synaptic Transmission; Tetraethylammonium; Time Factors; Triazines; Uridine Triphosphate; Vasodilator Agents | 2003 |
Activators of the PKA and PKG pathways attenuate RhoA-mediated suppression of the KDR current in cerebral arteries.
Topics: 4-Aminopyridine; ADP Ribose Transferases; Animals; Botulinum Toxins; Bucladesine; Cerebral Arteries; Colforsin; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Delayed Rectifier Potassium Channels; Dibutyryl Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Female; In Vitro Techniques; Membrane Potentials; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Nitroprusside; Patch-Clamp Techniques; Potassium; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; rhoA GTP-Binding Protein; Signal Transduction; Time Factors; Uridine Triphosphate; Vasoconstriction; Vasoconstrictor Agents | 2007 |